Antitumor Effect of Nanoparticle 131I-Labeled Arginine-Glycine-Aspartate-Bovine Serum Albumin-Polycaprolactone in Lung Cancer.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  AJR. American journal of roentgenology

• Publication date

  2017-03-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.2214/AJR.16.16947PMID 28301223
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• (99m)Tc-Labeled Multifunctional Low-Generation Dendrimer-Entrapped Gold Nanoparticles for Targeted SPECT/CT Dual-Mode Imaging of Tumors.

  2016cited by this paper
• Radionuclide therapy using 131I-labeled anti-epidermal growth factor receptor-targeted nanoparticles suppresses cancer cell growth caused by EGFR overexpression

  2016cited by this paper
• A new cyclic RGD peptide dimer for integrin αvβ3 imaging.

  2016cited by this paper
• Anti-tumor activity of lipophilic imidazolium salts on select NSCLC cell lines

  2015cited by this paper
• RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancer

  2015cited by this paper
• PIWIL2 promotes progression of non-small cell lung cancer by inducing CDK2 and Cyclin A expression

  2015cited by this paper
• Tumor-specific targeting by Bavituximab, a phosphatidylserine-targeting monoclonal antibody with vascular targeting and immune modulating properties, in lung cancer xenografts.

  2015cited by this paper
• Radiosynthesis and micro-SPECT analysis of triazole-based RGD integrin ligands as non-peptide molecular imaging probes for angiogenesis.

  2015cited by this paper
• Photo-thermal effect enhances the efficiency of radiotherapy using Arg-Gly-Asp peptides-conjugated gold nanorods that target αvβ3 in melanoma cancer cells

  2015cited by this paper
• Self-assembled biodegradable protein-polymer vesicle as a tumor-targeted nanocarrier.

  2014cited by this paper
• Imaging Integrin αvβ3 on Blood Vessels with 111In-RGD2 in Head and Neck Tumor Xenografts

  2014cited by this paper
• Anti-tumor Effect of Integrin Targeted 177Lu-3PRGD2 and Combined Therapy with Endostar

  2014cited by this paper
• Amphipathic tail-anchoring peptide is a promising therapeutic agent for prostate cancer treatment

  2014cited by this paper
• Two ⁹⁰Y-labeled multimeric RGD peptides RGD4 and 3PRGD2 for integrin targeted radionuclide therapy.

  2011cited by this paper
• Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.

  2010cited by this paper
• Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent.

  2010cited by this paper
• Radioimmunotherapy of human colon cancer xenografts with 131I-labeled anti-CEA monoclonal antibody.

  2010cited by this paper
• Cilengitide: an integrin-targeting arginine–glycine–aspartic acid peptide with promising activity for glioblastoma multiforme

  2008cited by this paper
• Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme.

  2008cited by this paper
• Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule.

  2007cited by this paper
• Targeting of the Antivascular Drug Combretastatin to Irradiated Tumors Results in Tumor Growth Delay

  2005cited by this paper
• Multidisciplinary management of lung cancer.

  2004cited by this paper
• Accuracy of 131I tumor quantification in radioimmunotherapy using SPECT imaging with an ultra-high-energy collimator: Monte Carlo study.

  2000cited by this paper

• Recent advancement on albumin nanoparticles in treating lung carcinoma

  2023cites this paper
• The Role of Integrins for Mediating Nanodrugs to Improve Performance in Tumor Diagnosis and Treatment

  2023cites this paper
• Radionuclide-based theranostics — a promising strategy for lung cancer

  2023cites this paper
• Cancer Brachytherapy at the Nanoscale: An Emerging Paradigm

  2023cites this paper
• The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors

  2021cites this paper
• (cRGD)2 peptides modified nanoparticles increase tumor-targeting therapeutic effects by co-delivery of albendazole and iodine-131

  2021cites this paper
• Nanotargeted radiopharmaceuticals for cancer theranostics

  2021cites this paper
• Preclinical SPECT and SPECT-CT in Oncology.

  2020cites this paper
• Molecular Imaging in Oncology

  2020cites this paper
• Aminosilanized flower-structured superparamagnetic iron oxide nanoparticles coupled to 131I-labeled CC49 antibody for combined radionuclide and hyperthermia therapy of cancer.

  2020cites this paper
• Smart solution of severe problems: Radiolabeled nanocarriers for cancer imaging and therapy

  2020cites this paper
• Mathematical modeling in cancer nanomedicine: a review

  2019cites this paper
• Liposome-Based Drug Delivery for Lung Cancer

  2019cites this paper
• Review of Therapeutic Applications of Radiolabeled Functional Nanomaterials

  2019cites this paper
• Correction to: a facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanoparticles in urethane-induced lung cancer: Bcl-2, MMP-9, caspase-9, and BAX as potential markers

  2019cites this paper
• A facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanoparticles in urethane-induced lung cancer: Bcl-2, MMP-9, caspase-9, and BAX as potential markers

  2018cites this paper
• Preclinical PET and SPECT for Radionanomedicine

  2018cites this paper
• Radiolabeled Nanoparticles in Nuclear Oncology

  2018cites this paper
• A Monte Carlo model for the internal dosimetry of choroid plexuses in nuclear medicine procedures.

  2018cites this paper